About: Rationale for the ASSAIL-MI-trial: a randomised controlled trial designed to assess the effect of tocilizumab on myocardial salvage in patients with acute ST-elevation myocardial infarction (STEMI)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Rationale for the ASSAIL-MI-trial: a randomised controlled trial designed to assess the effect of tocilizumab on myocardial salvage in patients with acute ST-elevation myocardial infarction (STEMI) Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 15 October 2019

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) artículu científicu espublizáu n'ochobre de 2019 (ast) im Oktober 2019 veröffentlichter wissenschaftlicher Artikel (de) наукова стаття, опублікована 15 жовтня 2019 (uk) scientific article published on 15 October 2019 (en)
publication date	wds:Q91047010-527DAF4A-6199-43D2-A358-7434499E447D
publication date	2019-10-15 00:00:00Z (xsd:dateTime)
author name string	wds:Q91047010-80146A63-995B-4D7B-B505-1432588A711B wds:Q91047010-94856BE9-C7E8-485E-BD80-A28E59FD8D4A wds:Q91047010-991E482A-AB9B-48D2-99B2-0965D35E7FE8 wds:Q91047010-CA30C489-5F47-4A94-9483-EE8C1FAF8D70 wds:Q91047010-DCAB6559-017B-40AC-9086-4D975555EB79 wds:Q91047010-E4E34D88-89EA-44A8-BF27-2813C981256E
author name string	Anders Opdahl Kapil Sharma Nils-Einar Kløw Einar Hopp Knut Haakon Stensæth Sindre Woxholt
rdfs:label	Rationale for the ASSAIL-MI-trial: a randomised controlled trial designed to assess the effect of tocilizumab on myocardial salvage in patients with acute ST-elevation myocardial infarction (STEMI) (en) Rationale for the ASSAIL-MI-trial: a randomised controlled trial designed to assess the effect of tocilizumab on myocardial salvage in patients with acute ST-elevation myocardial infarction (STEMI) (nl)
skos:prefLabel	Rationale for the ASSAIL-MI-trial: a randomised controlled trial designed to assess the effect of tocilizumab on myocardial salvage in patients with acute ST-elevation myocardial infarction (STEMI) (en) Rationale for the ASSAIL-MI-trial: a randomised controlled trial designed to assess the effect of tocilizumab on myocardial salvage in patients with acute ST-elevation myocardial infarction (STEMI) (nl)
name	Rationale for the ASSAIL-MI-trial: a randomised controlled trial designed to assess the effect of tocilizumab on myocardial salvage in patients with acute ST-elevation myocardial infarction (STEMI) (en) Rationale for the ASSAIL-MI-trial: a randomised controlled trial designed to assess the effect of tocilizumab on myocardial salvage in patients with acute ST-elevation myocardial infarction (STEMI) (nl)
author	wds:Q91047010-0BF9850E-051B-4EDA-8A49-2755FE0184FD wds:Q91047010-22D1FBA2-A60B-4B23-81CA-B3ABB23D4AFE wds:Q91047010-230178EE-FCBC-455F-843F-EAA572202389 wds:Q91047010-2C628862-2C54-4C8B-ADE3-EB4DF2F1892B wds:Q91047010-382F3558-A5BD-4E74-9786-E8D717323B95 wds:Q91047010-58E93960-959B-4802-B9F4-734B3EC2CB10 wds:Q91047010-6B411F7C-7841-4833-863E-20D85D36C709 wds:Q91047010-79B6BE45-18E3-45CE-A763-272EFFF7E89E wds:Q91047010-7D6D35DD-AD26-4292-859A-627A2CF0C8EB wds:Q91047010-BDAD86E2-6E5C-4C43-A456-F7F8C42E26DE wds:Q91047010-C0A559CC-A449-4389-8022-C9ABDF06992D wds:Q91047010-D03A34D8-E58F-440D-ACFD-31E078CE53D2 wds:Q91047010-E61FF02B-1D04-4190-B293-D0918F2C96D5
author	Pål Aukrust Jan Kristian Damås Lars Gullestad Thor Ueland Svend Aakhus Kaspar Broch Ingebjørg Seljeflot Brage H Amundsen Geir Øystein Andersen Bjørn Bendz Ola Kleveland Rune Wiseth Anne Kristine Anstensrud
title	wds:Q91047010-980823B3-62CB-4E43-8D7F-4D11784EC61F
title	Rationale for the ASSAIL-MI-trial: a randomised controlled trial designed to assess the effect of tocilizumab on myocardial salvage in patients with acute ST-elevation myocardial infarction (STEMI) (en)
page(s)	wds:Q91047010-1E3AF328-20A2-457F-B824-04DE8CA96DE5
page(s)	e001108
instance of	wds:Q91047010-213B91F2-4483-4C7A-BAAA-3F707A0E7119
instance of	scholarly article
main subject	wds:Q91047010-029CFA29-E241-4BDD-84C4-80812E7E1043
main subject	tocilizumab
PubMed ID	wds:Q91047010-BE7EED35-A1BF-4EE5-9978-5C47C9C138E9
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/31673391
PubMed ID	31673391
published in	wds:Q91047010-69633E15-4109-4C3A-AEEB-5D953474644B
published in	Open heart
issue	wds:Q91047010-77498D41-0834-4C43-900B-0297CFFA1F1A
volume	wds:Q91047010-A16D7E5E-A311-4880-8112-4B9F33AF1684
issue	2
volume	6
DOI	wds:Q91047010-D63C09C5-B481-458E-9CF7-07AA74696A76
DOI	http://dx.doi.org/10.1136/OPENHRT-2019-001108
DOI	10.1136/OPENHRT-2019-001108
PMCID	wds:Q91047010-F140F66F-E4D9-4ECB-9665-0C279F31A0D8
PMCID	6803013
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q91047010
is cites work of	Using proximity extension proteomics assay to identify biomarkers associated with infarct size and ejection fraction after ST-elevation myocardial infarction
is cites work of	wds:Q101121110-94819758-D7F0-4CD9-9BCB-71639AE3A450

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software